Status:
COMPLETED
Trimethylamine N-oxide in Myocardial Infarction
Lead Sponsor:
Yokohama City University Medical Center
Conditions:
Myocardial Infarction
Eligibility:
All Genders
20-100 years
Brief Summary
Trimethylamine-N-oxide (TMAO) is produced from the metabolism of gut microbiota and is reportedly pro-atherogenic and associated with cardiovascular events. The purpose of this study is to investigate...
Detailed Description
This study includes patients with their first STEMI. The investigators measure plasma TMAO levels using the frozen plasma at the onset of STEMI and 10 months later (the chronic phase). To assess plaqu...
Eligibility Criteria
Inclusion
- Patients who admitted to the Yokohama City University Medical Center with the diagnosis of their first STEMI and who underwent primary percutaneous coronary intervention within 12 hours after onset and received follow-up coronary angiogram 10 months after the index intervention.
Exclusion
- none
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT03418285
Start Date
January 1 2007
End Date
January 1 2018
Last Update
February 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.